IMS Health Institute Opens in Singapore

The IMS Institute for Healthcare Informatics has opened a branch in Singapore, where it will build relationships in the public and private sectors, and apply analytics-driven approaches for disease modelling and insights.

Part of pharma data giant IMS Health, the institute works with healthcare experts from across academia and the public and private sectors to use its parent company's proprietary information and analytical assets to give policy setters and decision makers insights into healthcare. Adding to branches in China and India, the Singapore institute's activities will focus on advancing decision analytics in clinical practice and public policymaking; connecting clinical, economic, and patient-reported outcomes data; and bringing together policy advisors, educators, researchers, and medical care providers to initiate research activities.

Murray Aitken (pictured), Executive Director of the Institute, comments: 'Like their peers around the globe, stakeholders across Asia are under increasing pressure to transform the focus of healthcare systems from volume to value. With growing recognition of the importance of real-world health data and analytics, our Asia branch will establish collaborative platforms that will bring stakeholders together to inform clinical and public policy decision making - addressing the 'triple aim' of population health, patient satisfaction and sustainable service costs'.

Web site: www.imshealth.com .